Ying Wang
Assistant ProfessorAbout
Dr. Wang is a Michael Smith Health Research BC Scholar and Heart and Stroke Foundation of Canada New Investigator. She obtained her PhD from Faculty of Pharmaceutical Sciences, University of British Columbia. During her Postdoctoral training at the Centre for Heart Lung Innovation and Stanford University, she received several prestigious international awards, including the Elaine W. Raines Early Career Investigator Award, the American Heart Association Postdoctoral Fellowship, and the Junior Investigator Award by Fondation Leducq PlaqOmics Trans-Atlantic Consortium. Upon joining UBC in 2021, she has attracted >1.8 million research funding as the principal investigator. Dr. Wang was appointed as the Director of Bruce McManus Cardiovascular Biobank in 2022. This 30-year-old biobank has the largest collections of explanted heart and heart valves in Canada. Dr. Wang’s lab embraces a can-do attitude to transcend the boundaries between disciplines, push back the limits of traditional methods, and address knowledge gaps in cardiovascular medicine. They welcome committed trainees to apply when opportunities are open.
For graduate students, please refer to: https://grad.pathology.ubc.ca/admissions/applying-to-our-program/
For undergraduate students, please refer to UBC Directed studies, SSRP, and Co-Op study programs.
Education & Training
- Post-doctoral fellow, Department of Vascular Surgery, Stanford University, Stanford, US.
- Post-doctoral fellow, Department of Medicine, University of British Columbia, Vancouver.
- PhD, Pharmaceutical Sciences, University of British Columbia.
- MSc, Pharmacology, Wuhan University, China.
- BSc, Pharmaceutical Sciences, Wuhan University, China.
Area of Interest
Dr. Wang’s research is focused on studying cell-cell and cell-microenvironment interactions to determine why diseased cells accumulate in the atherosclerotic lesions and how we can remove them. ‘Functional omics on a tissue slide’ is the current theme of Dr. Wang’s research. With a combination of biobank associated studies, spatial biology technology, and molecular biology, researchers in the Wang Lab aim to develop new therapeutic and diagnostic tools for better treatment and prediction of atherosclerotic disease.
Team Members
- Maria Elishaev
- Melody Wan-Hei Cheng
- Boaz Li
- Samuel Leung
- Yuancheng Mao
- Julia Kong
- Dr. Gurpreet Singhera (Biobank)
- Coco Ng (Biobank)
- Tiffany Chang (Biobank)